Concepedia

Author

Chiara Dalle Fratte

Istituti di Ricovero e Cura a Carattere ScientificoORCID

Also Known As

C. Dalle Fratte, Chiara Dalle Fratte, Dalle Fratte Chiara

23

Publications

324

Citations

9

H-Index

6

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere ScientificoCentro di Riferimento OncologicoUniversity of North Carolina at Chapel Hill
CD

About

Chiara Dalle Fratte is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in oncology, cancer therapeutics, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

49

2

Pathology

1

1

49

3

Cancer Therapeutics

1

1

49

4

Cancer Research

1

1

49

5

Oncology

1

1

49

Chiara Dalle Fratte

×

5

Publications

163

Citations

5

H-Index

YearCitations

The Genotype for <i><scp>DPYD</scp></i> Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice

Giuseppe Toffoli, Federico Innocenti, Jerry Polesel,

Clinical Pharmacology & Therapeutics

2018

50

Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity

Vasileios Fragoulakis, Rossana Roncato, Chiara Dalle Fratte,

The American Journal of Human Genetics

2019

49

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA

Steffen Dietz, Petros Christopoulos, Zhao Yuan,

EBioMedicine

2020

41

<i>CYP2D6</i> and <i>CYP2C8</i> pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients

Chiara Dalle Fratte, Sara Gagno, Rossana Roncato,

British Journal of Clinical Pharmacology

2022

12

Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib

Chiara Dalle Fratte, Michela Guardascione, Elena De Mattia,

Frontiers in Pharmacology

2020

11

Page 1